DONALD MAHONEY, JR. to Administration, Oral
This is a "connection" page, showing publications DONALD MAHONEY, JR. has written about Administration, Oral.
Connection Strength
0.184
-
Does intravenous 6-mercaptopurine decrease salvage after relapse in childhood acute lymphoblastic leukemia? Pediatr Blood Cancer. 2006 May 01; 46(5):660-1.
Score: 0.055
-
Barriers to and Facilitators of Iron Therapy in Children with Iron Deficiency?Anemia. J Pediatr. 2020 04; 219:202-208.
Score: 0.036
-
Acute neurotoxicity in children with B-precursor acute lymphoid leukemia: an association with intermediate-dose intravenous methotrexate and intrathecal triple therapy--a Pediatric Oncology Group study. J Clin Oncol. 1998 May; 16(5):1712-22.
Score: 0.032
-
Intermediate-dose intravenous methotrexate with intravenous mercaptopurine is superior to repetitive low-dose oral methotrexate with intravenous mercaptopurine for children with lower-risk B-lineage acute lymphoblastic leukemia: a Pediatric Oncology Group phase III trial. J Clin Oncol. 1998 Jan; 16(1):246-54.
Score: 0.031
-
Repetitive low dose oral methotrexate and intravenous mercaptopurine treatment for patients with lower risk B-lineage acute lymphoblastic leukemia. A Pediatric Oncology Group pilot study. Cancer. 1995 May 15; 75(10):2623-31.
Score: 0.026
-
Intensive alternating drug pairs for treatment of high-risk childhood acute lymphoblastic leukemia. A Pediatric Oncology Group pilot study. Cancer. 1993 May 01; 71(9):2854-61.
Score: 0.006